Alkem Labs gets US FDA's nod to market generic of Azasan drug

Alkem Labs gets US FDA's nod to market generic of Azasan drug

The US Food and Drug Administration has given its consent to Alkem Laboratories Ltd to market Azathioprine tablets, an update on the drug regulator's website showed.

AgenciesUpdated: Wednesday, April 01, 2020, 10:23 AM IST
article-image

Azathioprine is a generic version of AAIPharma LLC's Azasan drug, used to prevent a patient's body from rejecting a transplanted kidney. Azathioprine is also used to treat symptoms of rheumatoid arthritis. Alkem's azathioprine drug will be available in 25-mg, 50-mg, 75-mg, and 100-mg strengths. At 0935 IST, shares of the drug maker were up nearly 1% at 2,345.20 rupees on the National Stock Exchange.

RECENT STORIES

'Gutter Snan' For Aman Gupta; Instagram User Calls Him 'Fraud', Alleges Financial Irregularities...

'Gutter Snan' For Aman Gupta; Instagram User Calls Him 'Fraud', Alleges Financial Irregularities...

GST Reduction To Cut Consumer Price Index Inflation By 25 Basis Points, Could Reduce 35 BSP: SBI...

GST Reduction To Cut Consumer Price Index Inflation By 25 Basis Points, Could Reduce 35 BSP: SBI...

Government-Supported AIFs Invest ₹2,839 Crore In 154 Women-Led Startups

Government-Supported AIFs Invest ₹2,839 Crore In 154 Women-Led Startups

Insurance Laws Amendment Bill, 2025, Which Raised FDI Limit To 100%, Will Attract Capital & Support...

Insurance Laws Amendment Bill, 2025, Which Raised FDI Limit To 100%, Will Attract Capital & Support...

India Remains A Bright Spot Amid Global Uncertainty, With Robust 6.5% Growth Rate & Strong Domestic...

India Remains A Bright Spot Amid Global Uncertainty, With Robust 6.5% Growth Rate & Strong Domestic...